Statin-associated necrotizing autoimmune myopathy

Mod Rheumatol. 2014 Sep;24(5):862-4. doi: 10.3109/14397595.2013.874739. Epub 2014 Feb 11.

Abstract

Necrotizing autoimmune myopathy (NAM) is a severe adverse effect of statins. We report a 66-year-old Caucasian female who had progressive proximal muscle weakness after treatment with statins. Results of a muscle biopsy showed necrotizing myopathy with minimal inflammatory cell infiltrate and increased major histocompatibility class I antigen expression in muscle fibers. The clinical and laboratory parameters improved significantly with immunosuppressive treatment. Although it is a rare event, statin-induced NAM should be included as a differential diagnosis of myopathies.

Keywords: Dyslipidemia; Myopathy; Myositis; Necrotizing autoimmune myopathy; Statin.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Autoimmune Diseases / chemically induced*
  • Autoimmune Diseases / pathology
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / drug therapy
  • Muscle, Skeletal / pathology
  • Muscular Diseases / chemically induced*
  • Muscular Diseases / pathology

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors